Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
Cwm LLC Sells 32,785 Shares of QuidelOrtho Corporation $QDEL
03:46am, Thursday, 15'th Jan 2026
Cwm LLC lessened its stake in shares of QuidelOrtho Corporation (NASDAQ: QDEL) by 82.9% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 6,765 shares
Squarepoint Ops LLC Purchases Shares of 23,774 QuidelOrtho Corporation $QDEL
05:08am, Wednesday, 24'th Dec 2025
Squarepoint Ops LLC acquired a new position in QuidelOrtho Corporation (NASDAQ: QDEL) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Innovating Diagnostics and What's Next
09:17am, Thursday, 18'th Dec 2025
SAN DIEGO , Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jonathan Sieg
Frontier Capital Management Co. LLC Has $21.29 Million Stock Holdings in QuidelOrtho Corporation $QDEL
04:12am, Friday, 12'th Dec 2025
Frontier Capital Management Co. LLC lifted its position in QuidelOrtho Corporation (NASDAQ: QDEL) by 37.6% in the second quarter, according to its most recent Form 13F filing with the Securities and E
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
09:00am, Sunday, 07'th Dec 2025
New York City-based Newtyn Management bought 994,332 shares of QuidelOrtho Corporation in the third quarter, increasing its position by an estimated $30.4 million. At quarter-end, the firm reported ho
QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
03:43pm, Wednesday, 03'rd Dec 2025
QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Ameritas Investment Partners Inc. Invests $200,000 in QuidelOrtho Corporation $QDEL
03:26am, Monday, 01'st Dec 2025
Ameritas Investment Partners Inc. bought a new stake in QuidelOrtho Corporation (NASDAQ: QDEL) during the undefined quarter, according to the company in its most recent 13F filing with the Securities
QuidelOrtho To Participate In Upcoming Investor Conferences
07:00am, Monday, 24'th Nov 2025
SAN DIEGO , Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team will par
The Power of Prevention: Detecting Diabetes Before It Strikes
09:00am, Thursday, 20'th Nov 2025
SAN DIEGO , Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian Ding, MD
Bank of New York Mellon Corp Has $12.35 Million Position in QuidelOrtho Corporation $QDEL
03:40am, Wednesday, 19'th Nov 2025
Bank of New York Mellon Corp increased its stake in shares of QuidelOrtho Corporation (NASDAQ: QDEL) by 3.0% during the undefined quarter, according to the company in its most recent disclosure with t
QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand
02:26pm, Thursday, 06'th Nov 2025
QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.
QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call Transcript
05:46am, Thursday, 06'th Nov 2025
QuidelOrtho Corporation ( QDEL ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Juliet Cunningham - Vice President of Investor Relations Brian Blaser - President, CEO & Direct
QuidelOrtho Reports Third Quarter 2025 Financial Results
04:05pm, Wednesday, 05'th Nov 2025
― Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ― ― Successful completion of debt re
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
07:00am, Monday, 03'rd Nov 2025
Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction SAN DIEGO , Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administrat
Focus Partners Advisor Solutions LLC Cuts Stock Holdings in QuidelOrtho Corporation $QDEL
03:59am, Sunday, 02'nd Nov 2025
Focus Partners Advisor Solutions LLC lowered its position in shares of QuidelOrtho Corporation (NASDAQ: QDEL) by 31.4% in the second quarter, according to its most recent Form 13F filing with the Secu
